PharmiNews

The Directory of Pharma Companies and News

Salix

Category:
Category:

Salix News

DateNews
2015-03-16Valeant and Salix Agree on Amended Terms to Merger Agreement
2015-03-11Salix Pharmaceuticals, Ltd. Confirms Receipt of an Unsolicited Proposal from Endo International plc
2015-03-02Salix Pharmaceuticals Reports 4Q2014 and FY2014 Results
2015-02-25Salix Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 1.5% Convertible Senior Notes Due 2...
2015-02-25Salix Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 2.75% Convertible Senior Notes Due ...
2015-02-22Valeant to Acquire Salix Pharmaceuticals for $158.00 Per Share in Cash
2015-02-16Salix Pharmaceuticals Announces 4Q and FY2014 Financial Results Conference Call and Webcast
2015-02-02Salix Announces the Promotion of William P. Forbes, PharmD to President, Medical, R&D and Chief Development Officer
2015-01-28Salix Provides Update on Audit Committee Review
2015-01-08Pharming and Salix Announce First Patient Treated in Clinical Study of Ruconest® for Prophylaxis of Hereditary Angioedem...
2015-01-05Carolyn Logan to Retire as Chief Executive Officer of Salix Pharmaceuticals
2014-12-16Salix Pharmaceuticals Provides Updates on Wholesaler Inventory Reductions and the XIFAXAN® 550 for IBS-D Approval Timeli...
2014-11-24Salix Pharmaceuticals Announces Plan to Augment Board of Directors
2014-11-06Salix Pharmaceuticals Reports 3Q2014 Results
2014-11-06Salix Pharmaceuticals Appoints Acting Chief Financial Officer
2014-11-03Salix and Pharming Announce the Launch of RUCONEST® in the U.S. for the Treatment of Acute Angioedema Attacks in Patient...
2014-10-23Salix Pharmaceuticals Announces 3Q2014 Financial Results Conference Call and Webcast
2014-10-21Salix’s TARGET 3 Study Examines the Safety and Efficacy of Repeat Treatment with Rifaximin 550 mg for Irritable Bowel Sy...
2014-10-17Salix Pharmaceuticals Outlines Data Presentations at American College of Gastroenterology 2014 Annual Scientific Meeting
2014-10-08FDA Approves UCERIS® (Budesonide) 2mg Rectal Foam for the Induction of Remission of Mild-to-Moderate Distal Ulcerative C...
2014-10-03Salix Pharmaceuticals and Cosmo Technologies Announce Termination of Merger Agreement
2014-09-29FDA Approves RELISTOR® Subcutaneous Injection for the Treatment of Opioid-Induced Constipation in Patients with Chronic ...
2014-09-18Salix Announces FDA User Fee Goal Date of February 28, 2015 for XIFAXAN® 550mg sNDA for Treatment of Irritable Bowel Syn...
2014-09-18Salix Secures Additional Intellectual Property Relating to Rifaximin
2014-09-15UCERIS® (budesonide) 2mg Rectal Foam for the Induction of Remission of Mild-to-Moderate Distal Ulcerative Colitis Grante...
2014-09-02Salix Submits Response to XIFAXAN® 550mg Complete Response Letter Regarding Repeat Treatment for Irritable Bowel Syndrom...
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.